ICT&health December 10, 2025
AI-enhanced wearables are rapidly reshaping how people manage Type 2 diabetes and prediabetes. A new meta-review from the University at Buffaloprovides the clearest picture yet of what these devices can offer, and what must still be resolved before they become routine in diabetes care. It is the first comprehensive analysis to consolidate findings from thousands of studies on AI-driven wearables, including continuous glucose monitors (CGMs), activity trackers and multimodal biosensors.
Lead researcher Dr. Raphael Fraser explains that AI fundamentally changes the role of glucose monitoring. Traditional CGMs provide a few readings per day, while AI-enhanced CGMs deliver continuous insights, flagging trends and even predicting glucose shifts 60 to 120 minutes ahead. “AI turns CGMs from a rear-view mirror into a...
Today's Sponsors
Today's Sponsor